Announcement: Raffles Obtains “Drug Manufacturing License”
30 November 2022,Raffles PharmaTech has successfully obtained a Drug Manufacturing License issued by the Guangdong NMPA, certificate No.粤20220025,classification code Dh.
The recognition by the regulatory authority marks an important development milestone for the company.
About Us
1. Raffles PharmaTech was created in 2011 by scientists from leading global companies driven to build a platform for world-class small molecule development and cGMP manufacturing.
2. The company with head-quarters in Guangdong, China, currently employs more than 450 staff supporting Innovative pharmaceutical development across the globe.
3. With Chemistry at the core of the organization the company engages in route discovery,process development, optimization,scale-up and cGMP manufacture of Key materials, Intermediates, Active Pharmaceutical Ingredients.
HOME
CONTACT US
· Phone: 0755-84235114
· E-mail: BD@rafflespt.com
ABOUT
RAFFLES
SERVICES AND SOLUTIONS
CORE CAPABILITIES
NEWS
3D GMP PLANT
echnical support: Husan粤ICP备13012904号